Early weight loss responders to liraglutide 3.0 mg achieved greater weight loss and regression to normoglycaemia, and reduced development of T2D at 3 years, versus early nonresponders in the SCALE obesity and prediabetes trial [abstract]
Depending on your BMI, health history, lab results, and goals, we may discuss lifestyle treatment, medical weight loss, GLP-1 medications, GLP-1/GIP therapies, or bariatric surgery evaluation when clinically appropriate
6.2 Liver fibrosis/Cirrhosis The progression of fibrosis generally stems from the activation of pro-fibrogenic immune cells, such as M2 cells, which follow inflammatory immune cells that cause injury
Your doctor may order extra blood tests to keep you safe
Long-acting formulations, such as dulaglutide, liraglutide, and once-weekly exenatide, have consistently shown superior efficacy in reducing both fasting plasma glucose and HbA1c levels when compared to shorter-acting alternatives like twice-daily exenatide and lixisenatide (Htike et al
